
iVeena completes end-of-phase 1 FDA meeting for IVMED-85 in myopia
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNTDdYVGpLMkNqVXpkb1NzcXBRME91cFV3OXRHSWw0U1N5UDZ0ZndjZUlwMFZLbjRFd0hYTy1zb3p4OGtvR1F2eExtZ0N3bmJnNlNieHlBOEU1Z09UaFd3VmpBcnc2T2VaOHpuUXYzM3hVNTNuajBFNi10YVZHOFZHZEl4M0swbTIwWnRRT2ZLMUo5SnAzc01BMTEwczlZVHZ2aWZ5VA?oc=5" target="_blank">iVeena completes end-of-phase 1 FDA meeting for IVMED-85 in myopia</a>&nbsp;&nbsp;<font color="#6f6f6f">Optometry Times</font>